INFORMATION ON CAPITAL INCREASE DUE TO THE COMPANY'S STOCK OPTION PLAN APPROVED BY THE BOARD OF DIRECTORS IN MEETING HELD ON MAY 05, 2021.

In compliance with article 30 of CVM Rule No 480/09, as amended, the Company hereby provides the information required in the Exhibit 30-XXXII of such Rule, regarding the capital increase approved by the Company's Board of Directors on May 05, 2021, due to the exercise of stock options granted to certain employees under the Company's stock option plans, as follows:

1. Date of the shareholders meeting in which the stock option plan was approved

On May 9, 2014 our shareholders approved, in an Extraordinary Shareholders Meeting the creation of a Stock Option Plan and its standard option agreement ('Stock Option Plan') and the creation of a Compensation in Stock Option Plan and its standard option agreement ('Compensation Plan', jointly with the Stock Option Plan, the 'Plans'). Amendments to the Plans were approved at the Annual and Special General Meeting held on April 24, 2015, at the Annual and Special General Meeting held on April 25, 2019 and at the Extraordinary General Meeting held on December 30, 2019. All shares issued in the capital increase approved herein derive from the Plans.

2. Amount of the capital increase and new capital stock

The approved capital increase is of R$ 23,517,280.08 (twenty-three million, five hundred and seventeen thousand, two hundred and eighty reais and eight cents).

After the increase, the Company's capital stock sums up to the total amount of R$ 5,873,383,865.77 (five billion, eight hundred and seventy three million, three hundred and eighty-three thousand, eight hundred and sixty-five reais and seventy-seven cents).

3. Number of shares issued of each type and class

This capital increase was approved through the issuance of 544,106 (five hundred and forty-four thousand and one hundred and six) common shares.

According to the Company's By-laws, such common shares hereby issued have the same characteristics and conditions and enjoy the same rights, benefits and advantages of other existing common shares issued by the Company, including dividends and other capital's remuneration that may be declared by the Company.

4. Issuance price of the new shares

(i) exercise of Series C4: R$ 56.78
(ii) exercise of Series B5: R$ 0.01
(iii) exercise of Series C5: R$ 62.61
(iv) exercise of Series B6: R$ 0.01
(v) exercise of Series C6: R$ 70.62
(vi) exercise of Series B7: R$ 0.01
(vii) exercise of Series C7: R$ 51.18
2

5. Price of each type and class of the issuer's shares in the markets in which they are traded:

Prior to the conversion of the preferred shares of the Company into common shares, such common shares did not possess market liquidity. Therefore, the Company presents below the prices of the common shares (PCAR3) from March 2nd, 2020 beyond, since this was the date in which the preferred shares ceased its negotiation and only common shares began being negotiated.

Price Apr/21 Mar/21 Feb/21
Avarage R$ 34.89 R$ 26.55 R$ 86.46
Maximum R$ 39.27 R$ 33.80 R$ 90.33
Minimum R$ 32.30 R$ 21.35 R$ 79.41

Average price for the last ninety (90) days (from February 1st, 2021, until April 14th, 2021): R$ 55.40

Preferred Shares (PCAR4)

a) minimum, average and maximum price in each year for the last three (3) years
Price 2020(*) 2019 2018 2017
Average R$ 86.11 R$ 88.04 R$ 77.20 R$ 68.03
Maximum R$ 91.70 R$ 98.43 R$ 87.51 R$ 80.85
Minimum R$ 72.04 R$ 78.00 R$ 63.92 R$ 54.30

(*) Until February 28th, 2020.

b) minimum, average and maximum price in each quarter of year for the last two (2) years
Price 1Q20(*) 4Q19 3Q19 2Q19 1Q19 4Q18 3Q18 2Q18 1Q18
Average R$ 86.11 R$ 82.59 R$ 88.58 R$ 89.18 R$ 92,66 R$ 81.72 R$ 80.57 R$ 75.71 R$ 70.78
Maximum R$ 91.70 R$ 90.08 R$ 94.50 R$ 98.43 R$ 98,14 R$ 86.68 R$ 87.51 R$ 82.15 R$ 78.99
Minimum R$ 72.04 R$ 78.00 R$ 79.80 R$ 79.14 R$ 82,77 R$ 77.76 R$ 74.60 R$ 66.48 R$ 63.92

(*) Until February 28th, 2020.

c) minimum, average and maximum price in each month for the last six (6) months
Price Jun/20 May/20 Apr/20(*) Mar/20(*) Feb/20 Jan/20
Average - - - - R$ 82.75 R$ 88.86
Maximum - - - - R$ 87.63 R$ 91.70
Minimum - - - - R$ 72.04 R$ 84.02

(*) The preferred shares ceased its negotiation on March 2nd, 2020.

3
d) average price for the last ninety (90) days (from October 16th, 2019 until February 28th, 2020)
Average R$ 84.31

6. Percentage of potential dilution resulting from the issuance

Percentage of dilution of 0.2023%.

4

Attachments

  • Original document
  • Permalink

Disclaimer

CBD - Companhia Brasileira de Distribuição published this content on 06 May 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 06 May 2021 20:01:42 UTC.